NO971768L - Hemoglobinreseptorer fra Neisseriae - Google Patents

Hemoglobinreseptorer fra Neisseriae

Info

Publication number
NO971768L
NO971768L NO971768A NO971768A NO971768L NO 971768 L NO971768 L NO 971768L NO 971768 A NO971768 A NO 971768A NO 971768 A NO971768 A NO 971768A NO 971768 L NO971768 L NO 971768L
Authority
NO
Norway
Prior art keywords
proteins
nucleic acids
antibodies
hemoglobin receptor
apples
Prior art date
Application number
NO971768A
Other languages
English (en)
Other versions
NO971768D0 (no
Inventor
Igor Stojiljkovic
Magdalene So
Vivian Hwa
Fred Heffron
Xavier Nassif
Original Assignee
Oregon Health Scienses Univers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/326,670 external-priority patent/US5698438A/en
Application filed by Oregon Health Scienses Univers filed Critical Oregon Health Scienses Univers
Publication of NO971768D0 publication Critical patent/NO971768D0/no
Publication of NO971768L publication Critical patent/NO971768L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår nye bakterielle hemogloblnreseptorprotelner og gener som koder for slike proteiner. Oppfinnelsen er rettet mot isolering, karakterisering, diagnostisk og terapeutisk anvendelse av bakterielle hemogloblnreseptorprotelner, nuklein- syrer kodende for slike proteiner, rekoinbinante ekspresjonskonstrukter omfattende slike nukleinsyrer og celler transformert til dette, og antistoffer og epltoper av slike hemoglobinreseptorproteiner. Oppfinnelsen angår spesielt hemogloblnreseptorprotelner og gener kodende for slike proteiner fra Nelsseria- arter, spesielt K. meningitldls og serotyper derav, og N. gonorrhoeae. Fremgangsmåter for diagnostisering og terapeutisk anvendelse av proteiner, epltoper, antistoffer og nukleinsyrer ifølge foreliggende oppfinnelse er også tilveiebragt, innbefattet anven- delse av proteiner, epltoper, antistoffer og nuklein- syrer ifølge oppfinnelsen for produksjon av vaksiner som er effektive i å tilveiebringe immunisering av et itienneske mot infeksjon av patogeniske bakterier av Neisseria-arter.
NO971768A 1994-10-18 1997-04-17 Hemoglobinreseptorer fra Neisseriae NO971768L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/326,670 US5698438A (en) 1994-10-18 1994-10-18 Bacterial hemoglobin receptor gene
US08/537,361 US6121037A (en) 1994-10-18 1995-10-02 Bacterial hemoglobin receptor genes
PCT/US1995/013623 WO1996012020A2 (en) 1994-10-18 1995-10-17 Hemoglobin receptors from neisseriae

Publications (2)

Publication Number Publication Date
NO971768D0 NO971768D0 (no) 1997-04-17
NO971768L true NO971768L (no) 1997-06-03

Family

ID=26985503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971768A NO971768L (no) 1994-10-18 1997-04-17 Hemoglobinreseptorer fra Neisseriae

Country Status (8)

Country Link
US (2) US6121037A (no)
JP (1) JPH10508469A (no)
AU (1) AU705509B2 (no)
CA (1) CA2203116A1 (no)
FI (1) FI971634A (no)
HU (1) HUT77048A (no)
NO (1) NO971768L (no)
WO (1) WO1996012020A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0749321B1 (en) * 1994-02-09 2007-01-24 Epitopix LLC Active immunization using a siderophore receptor protein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US6121037A (en) 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
CA2308606A1 (en) * 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
EP1144643A1 (en) * 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
DK1163343T3 (da) 1999-03-12 2010-04-19 Glaxosmithkline Biolog Sa Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
GB9911683D0 (en) * 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
AU784203B2 (en) 1999-10-29 2006-02-23 Glaxosmithkline Biologicals S.A. Neisserial antigenic peptides
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
CA2708949C (en) * 2001-01-03 2016-03-08 Epitopix Llc. Immunizing compositions and methods of use
ES2395022T3 (es) 2003-09-19 2013-02-07 Epitopix, Llc Polipéptidos de Campylobacter y sus métodos de uso
WO2010070453A2 (en) * 2008-12-17 2010-06-24 Novartis Ag Meningococcal vaccines including hemoglobin receptor
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5304487A (en) 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US6121037A (en) 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes

Also Published As

Publication number Publication date
AU705509B2 (en) 1999-05-27
FI971634A0 (fi) 1997-04-17
US6121037A (en) 2000-09-19
JPH10508469A (ja) 1998-08-25
US7026157B1 (en) 2006-04-11
WO1996012020A2 (en) 1996-04-25
FI971634A (fi) 1997-06-16
AU4007395A (en) 1996-05-06
NO971768D0 (no) 1997-04-17
CA2203116A1 (en) 1996-04-25
WO1996012020A3 (en) 1996-05-23
HUT77048A (hu) 1998-03-02

Similar Documents

Publication Publication Date Title
NO971768L (no) Hemoglobinreseptorer fra Neisseriae
Hayman et al. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.
CN113365656A (zh) 用于非洲猪瘟病毒的免疫原性组合物
EA015833B1 (ru) Иммуногенная композиция
CN101955545B (zh) 一种多靶点重组基因及其蛋白在防治幽门螺旋杆菌感染中的应用
CN101631858A (zh) 用于预防和治疗脑膜炎球菌疾病的新颖免疫原性组合物
CN1272062A (zh) 含有b组脑膜炎球菌膜孔蛋白和流感嗜血菌多糖的免疫偶联物
CN102256620A (zh) 用于治疗阿尔茨海默氏病的免疫治疗组合物
CN105142653A (zh) 增强对肠病原体免疫应答的组合物和方法
Khiav et al. Vaccination against pathogenic clostridia in animals: a review
CN101848997B (zh) 用于Myo-2肽多聚体和肌生成抑制素的融合蛋白表面表达载体以及由其转化的微生物
Golshani et al. Evaluation of Poly (I: C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice
Fatehi et al. Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus
KR100366482B1 (ko) 백신으로서 정제된 분류가능하지 않은 헤모필루스 인프루엔자 p5단백질, 및 그의 정제방법
BG98070A (bg) Получаване и използване на убити с формалин организми от вида е.соli, експресиращи антиген на колоний- образуващия фактор, за ваксиниране срещу чревни инфекции/диарии, причинени от ентеротоксични бактерии на e.coli у хората
CN109293753A (zh) 一种肠毒素型大肠杆菌四价纤毛蛋白免疫原及其制备方法
KR20130125771A (ko) 다가 키메라 ospc 백시노겐 및 진단 항원
Heesemann et al. Monoclonal antibodies directed against plasmid-encoded released proteins of enteropathogenic Yersinia
Akkoyunlu et al. The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate
CN104072590B (zh) 一种脑膜炎球菌抗原组合及其应用
Georgousakis et al. Moving forward: a mucosal vaccine against group A streptococcus
CN107970444A (zh) 复合佐剂及含有该复合佐剂的疫苗
CN115243715A (zh) 保护以对抗血清型9、序列型16的猪链球菌的疫苗
Robinson et al. Adult worm homogenate of the nematode parasite Heligmosomoides polygyrus induces proliferation of naive T lymphocytes without MHC restriction
EP0694560A2 (en) Production of antigens of Pasteurella

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application